Company / Operating Income
Cytosorbents Corp Operating Income History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$15.6M
FY2018
5-year range
-$15.6M / -$6.9M
FY2014-FY2018
Trend
-58.3%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$7M to -$16M over the past 2 years.
Based on SEC 10-K filings.
-$16M in FY2018.
Declined from -$7M to -$16M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, operating income decreased 58.3% year-over-year.
- Peak operating income was recorded in FY2013.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | -$15.6M | -58.3% |
| FY2017 | -$9.8M | -42.8% |
| FY2016 | -$6.9M | +25.9% |
| FY2015 | -$9.3M | -35.0% |
| FY2014 | -$6.9M | -97.5% |
| FY2013 | -$3.5M | +0.0% |
| FY2012 | -$3.5M | +21.3% |
| FY2011 | -$4.4M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026